Resting regional brain metabolism in social anxiety disorder and the effect of moclobemide therapy

Alex Doruyter; Patrick Dupont; Lian Taljaard; Dan Joseph Stein; Christine Löchner; James Warwick

doi:10.1007/s11011-017-0145-7

Back

Resting regional brain metabolism in social anxiety disorder and the effect of moclobemide therapy

Article 2017 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2016

Resting functional connectivity in social anxiety disorder and the effect of pharmacotherapy

Alex Doruyter, Christine Löchner, Gerhard P. Jordaan, Dan Joseph Stein, Patrick Dupont, James Warwick

Article2008

Resting brain perfusion in social anxiety disorder: A voxel-wise whole brain comparison with healthy control subjects

James Warwick, Paul D. Carey, Gerhard P. Jordaan, Patrick Dupont, Dan Joseph Stein

Article2015

Resting-state Functional Connectivity in Social Anxiety Disorder Compared to Healthy Controls and the Effect of Pharmacotherapy

Alex Doruyter, Christine Löchner, Patrick Dupont, Dan Joseph Stein, James Warwick

Article2017

Eight-week moclobemide pharmacotherapy improves clinical but not cognitive outcomes in social anxiety disorder

Lian Taljaard, Alex Doruyter, Dan Joseph Stein, Christine Löchner

Article2010

Changes in regional brain volumes in social anxiety disorder following 12 weeks of treatment with escitalopram

N Cassimjee, Jean-Pierre Fouche, Michael F. Burnett, Christine Löchner, James Warwick, Patrick Dupont, Dan Joseph Stein, Karen J. Cloete, Paul D. Carey